![Lester B. Salans](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lester B. Salans
Founder at Lbs Advisors, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Elijah M. Bolotin | M | - |
PharmaIN Corp.
![]() PharmaIN Corp. Pharmaceuticals: MajorHealth Technology PharmaIN Corp. develops affinity-based drug delivery solutions for biotech and pharmaceutical applications. It develops drug therapies using its proprietary, novel drug delivery platform called Protected Graft Co-polymer. The company was founded by Elijah M. Bolotin in 2000 and is headquartered in Bothell, WA. | 24 years |
John Presutti | M | - |
PharmaIN Corp.
![]() PharmaIN Corp. Pharmaceuticals: MajorHealth Technology PharmaIN Corp. develops affinity-based drug delivery solutions for biotech and pharmaceutical applications. It develops drug therapies using its proprietary, novel drug delivery platform called Protected Graft Co-polymer. The company was founded by Elijah M. Bolotin in 2000 and is headquartered in Bothell, WA. | - |
Kristján Tómas Ragnarsson | M | 80 |
Icahn School of Medicine at Mount Sinai
| - |
Tom Strauss | M | 82 |
Icahn School of Medicine at Mount Sinai
| - |
Gary Goldenberg | M | 47 |
Icahn School of Medicine at Mount Sinai
| 15 years |
John R. Tomasula | M | 69 |
Icahn School of Medicine at Mount Sinai
| 22 years |
Ross L. Cagan | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Barbara Paris | M | 72 |
Icahn School of Medicine at Mount Sinai
| 21 years |
Hina Waheed Chaudhry | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Tibor Papp | M | - |
PharmaIN Corp.
![]() PharmaIN Corp. Pharmaceuticals: MajorHealth Technology PharmaIN Corp. develops affinity-based drug delivery solutions for biotech and pharmaceutical applications. It develops drug therapies using its proprietary, novel drug delivery platform called Protected Graft Co-polymer. The company was founded by Elijah M. Bolotin in 2000 and is headquartered in Bothell, WA. | - |
Scott L. Friedman | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Robert J. Desnick | M | - |
Icahn School of Medicine at Mount Sinai
| 15 years |
Kevin David Costa | M | - |
Icahn School of Medicine at Mount Sinai
| 15 years |
Jeffrey Vacirca | M | 55 |
Icahn School of Medicine at Mount Sinai
| 6 years |
Sundar Jagannath | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Yuriy Rubin | M | - |
PharmaIN Corp.
![]() PharmaIN Corp. Pharmaceuticals: MajorHealth Technology PharmaIN Corp. develops affinity-based drug delivery solutions for biotech and pharmaceutical applications. It develops drug therapies using its proprietary, novel drug delivery platform called Protected Graft Co-polymer. The company was founded by Elijah M. Bolotin in 2000 and is headquartered in Bothell, WA. | - |
George M. Diaz | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Stephen Dahmer | M | 49 |
Icahn School of Medicine at Mount Sinai
| 9 years |
Peter Sordillo | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Joshua Brody | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Edward Lung | M | - |
Icahn School of Medicine at Mount Sinai
| 21 years |
Lisa Edelmann | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Lawrence Tanenbaum | M | 66 |
Icahn School of Medicine at Mount Sinai
| 16 years |
Judy Cho | F | - |
Icahn School of Medicine at Mount Sinai
| - |
Elissa Levin | F | - |
Icahn School of Medicine at Mount Sinai
| - |
Lisa Satlin | F | - |
Icahn School of Medicine at Mount Sinai
| - |
Sergey Rakhilin | M | - |
PharmaIN Corp.
![]() PharmaIN Corp. Pharmaceuticals: MajorHealth Technology PharmaIN Corp. develops affinity-based drug delivery solutions for biotech and pharmaceutical applications. It develops drug therapies using its proprietary, novel drug delivery platform called Protected Graft Co-polymer. The company was founded by Elijah M. Bolotin in 2000 and is headquartered in Bothell, WA. | - |
Alain Carpentier | M | 91 |
Icahn School of Medicine at Mount Sinai
| - |
Michael R. Hausman | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Eric Schadt | M | 59 |
Icahn School of Medicine at Mount Sinai
| 13 years |
Carlos Cordón-Cardó | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Steven J. Burakoff | M | 81 |
Icahn School of Medicine at Mount Sinai
| - |
Melvin M. van Woert | M | 93 |
Icahn School of Medicine at Mount Sinai
| 46 years |
Samuel Marcus Waxman | M | - |
Icahn School of Medicine at Mount Sinai
| 41 years |
Ariel Recanati | M | 60 |
Icahn School of Medicine at Mount Sinai
| - |
Daniel Moros | M | - |
Icahn School of Medicine at Mount Sinai
| 33 years |
Michael Donovan | M | 70 |
Icahn School of Medicine at Mount Sinai
| 13 years |
Stephen B. Thacker | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Holly G. Atkinson | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Francesco Ramirez | M | - |
Icahn School of Medicine at Mount Sinai
| - |
John H. Morrison | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Steve Hochberg | M | 62 |
Icahn School of Medicine at Mount Sinai
| - |
Andrew M. Saul | M | 77 |
Icahn School of Medicine at Mount Sinai
| - |
Janice L. Gabrilove | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Arthur A. Klein | M | 76 |
Icahn School of Medicine at Mount Sinai
| - |
Gerry Castillo | M | - |
PharmaIN Corp.
![]() PharmaIN Corp. Pharmaceuticals: MajorHealth Technology PharmaIN Corp. develops affinity-based drug delivery solutions for biotech and pharmaceutical applications. It develops drug therapies using its proprietary, novel drug delivery platform called Protected Graft Co-polymer. The company was founded by Elijah M. Bolotin in 2000 and is headquartered in Bothell, WA. | - |
E. Premkumar Reddy | M | 80 |
Icahn School of Medicine at Mount Sinai
| 14 years |
Hendrick Coenraad Hemker | M | 90 |
Icahn School of Medicine at Mount Sinai
| - |
Angela Diaz | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Jay Schechtman | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Preeti Parikh | M | - |
Icahn School of Medicine at Mount Sinai
| - |
Andrew Russell | M | 52 |
Icahn School of Medicine at Mount Sinai
| 9 years |
Dennis Charney | M | 72 |
Icahn School of Medicine at Mount Sinai
| 20 years |
Mark Edelsward | M | - |
PharmaIN Corp.
![]() PharmaIN Corp. Pharmaceuticals: MajorHealth Technology PharmaIN Corp. develops affinity-based drug delivery solutions for biotech and pharmaceutical applications. It develops drug therapies using its proprietary, novel drug delivery platform called Protected Graft Co-polymer. The company was founded by Elijah M. Bolotin in 2000 and is headquartered in Bothell, WA. | - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
United States | 54 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Lester B. Salans
- Personal Network